Mark T Iwicki

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
24 Feb 25	QTTB Q32 Bio	Stock Option Common Stock	Grant	Acquire A	No	No	2.54	25,534	64.86 k	25,534
24 Feb 25	QTTB Q32 Bio	Stock Option Common Stock	Sale back to company	Dispose D	No	No	16.82	25,534	429.48 k	0
24 Feb 25	QTTB Q32 Bio	Stock Option Common Stock	Grant	Acquire A	No	No	2.54	7,615	19.34 k	7,615
24 Feb 25	QTTB Q32 Bio	Stock Option Common Stock	Sale back to company	Dispose D	No	No	7.29	7,615	55.51 k	0
24 Feb 25	QTTB Q32 Bio	Stock Option Common Stock	Grant	Acquire A	No	No	2.54	37,222	94.54 k	37,222
24 Feb 25	QTTB Q32 Bio	Stock Option Common Stock	Sale back to company	Dispose D	No	No	7.29	37,222	271.35 k	0
21 Feb 25	IKT Inhibikase Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	2.23	602,346	1.34 mm	602,346
17 Feb 25	IKT Inhibikase Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	2.35	1,794,291	4.22 mm	1,794,291
14 Feb 25	IKT Inhibikase Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	2.35	4,373,857	10.28 mm	4,373,857
6 Jan 25	KALA Kala Pharmaceuticals	Common Stock	Sell	Dispose S	No	Yes	7.63	5,779	44.09 k	280,076

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.